|
||||||||||
|
General |
||||||||||
| Clinical Use: | Peripheral nervous system disease specifically associated with the clinical spectrum of acquired neuromyotonia (NMT) and cramp-fasciculation syndrome (CFS), and disorders of the central nervous system, including Morvan syndrome, epilepsy and limbic encephalitis (LE). | |||||||||
| Availability: | Samples are batched and tested once a week. | |||||||||
| Aliases/Synonyms: | Anti-CASPR2 Autoantibody (CSF), Anti-LG1 Autoantibody (CSF), Anti-VGKC Autoantibody (CSF), CASPR2 Autoantibody (CSF), Hippocampal Autoantibody (CSF), LG1 Autoantibody (CSF), VGKC Autoantibody (CSF), Voltage Gated Potassium Channel Antibody (CSF), | |||||||||
| Code: | VGPCC | |||||||||
| Handling Instructions (to laboratory): | Send sample chilled. | |||||||||
| Hyperlink: | https://pathwest.health.wa.gov.au/~/media/PathWest/Documents/Our-Services/Clinical-Services/Immunology/Testing-for-Neuroimmunology-Conditions-at-PathWest-Laboratory-Medicine.pdf | |||||||||
| Reference Interval: |
<85 pmol/L |
|||||||||
|
Collection Requirements |
||||||||||
| Container: | CSF Tube 1 (CSF1), | |||||||||
| Sample Type: | See container | |||||||||
| Minimum Collection Volume: | 150uL | |||||||||
| Collection Instructions: | ||||||||||
|
Processing Requirements |
||||||||||
| Alternate Containers: |
|
|||||||||
| Processing Instructions: | ||||||||||
| Minimum Assay Volume: | 150uL | |||||||||
| Stability: | 2 weeks chilled | |||||||||
| Transport Instructions (to testing laboratory): | Send sample chilled. | |||||||||
|
Testing Locations |
||||||||||
| Performed at: |
|
|||||||||
|
Last Updated : 04-03-2026 14:01 |
||||||||||